IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Mismatch Repair Deficient or MSI-High Solid Tumors
Shanghai Zhongshan Hospitalmonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 81/ 100
Competitive context
10 Active assets in the Mismatch Repair Deficient or MSI-High Solid Tumors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Carboplatin Shanghai Zhongshan Hospital | Phase 2 | CCC |
ETOPOSIDE Shanghai Zhongshan Hospital | Phase 2 | CCC |
Shr-8068 Shanghai Zhongshan Hospital | Phase 2 | CCC |
Capecitabine Shanghai Zhongshan Hospital | Phase 2 | CCC |
Eloxatin Shanghai Zhongshan Hospital | Phase 2 | CCC |
View all 11 →
Same molecule, other indications
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →